Mainz Biomed N.V. stock is down -48.31% since 30 days ago. The next earnings date is Sep 6, 2023. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 50% of the previous 2 November’s closed higher than October. 50% of analysts rate it a buy.
Mainz Biomed B.V. develops in-vitro diagnostic (IVD) and research use only tests for clinical diagnostics in human genetics. The company was founded in 2008 and is based in Mainz, Germany.